Literature DB >> 26555353

HIV testing uptake and retention in care of HIV-infected pregnant and breastfeeding women initiated on 'Option B+' in rural Zimbabwe.

Janet Dzangare1, Kudakwashe C Takarinda1,2, Anthony D Harries2,3, Katie Tayler-Smith4, Mutsa Mhangara1, Tsitsi Mutasa Apollo1, Angela Mushavi1, Anesu Chimwaza1, Ngwarai Sithole1, Tapiwa Magure5, Amon Mpofu5, Freeman Dube5, Owen Mugurungi1.   

Abstract

OBJECTIVES: Zimbabwe has started to scale up Option B+ for the prevention of mother-to-child transmission of HIV, but there is little published information about uptake or retention in care. This study determined the number and proportion of pregnant and lactating women in rural districts diagnosed with HIV infection and started on Option B+ along with six-month antiretroviral treatment (ART) outcomes.
METHODS: This was a retrospective record review of women presenting to antenatal care or maternal and child health services at 34 health facilities in Chikomba and Gutu rural districts, Zimbabwe, between January and March 2014.
RESULTS: A total of 2728 women presented to care of whom 2598 were eligible for HIV testing: 76% presented to antenatal care, 20% during labour and delivery and 4% while breastfeeding. Of 2097 (81%) HIV-tested women, 7% were HIV positive. Lower HIV testing uptake was found with increasing parity, late presentation to antenatal care, health centre attendance and in women tested during labour. Ninety-one per cent of the HIV-positive women were started on Option B+. Six-month ART retention in care, including transfers, was 83%. Loss to follow-up was the main cause of attrition. Increasing age and gravida status ≥2 were associated with higher six-month attrition.
CONCLUSION: The uptake of HIV testing and Option B+ is high in women attending antenatal and post-natal clinics in rural Zimbabwe, suggesting that the strategy is feasible for national scale-up in the country.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Investigación de Operaciones; Opción B+; Operational Research; Option B+; SORT IT; Zimbabue; Zimbabwe; recherche opérationnelle

Mesh:

Substances:

Year:  2015        PMID: 26555353     DOI: 10.1111/tmi.12637

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  24 in total

1.  Stepped-Wedge Cluster Randomized Controlled Trial to Promote Option B+ Retention in Central Mozambique.

Authors:  James T Pfeiffer; Manuel Napúa; Bradley H Wagenaar; Falume Chale; Roxanne Hoek; Mark Micek; João Manuel; Cathy Michel; Jessica Greenberg Cowan; James F Cowan; Sarah Gimbel; Kenneth Sherr; Stephen Gloyd; Rachel R Chapman
Journal:  J Acquir Immune Defic Syndr       Date:  2017-11-01       Impact factor: 3.731

2.  Evaluation of mHealth strategies to optimize adherence and efficacy of Option B+ prevention of mother-to-child HIV transmission: Rationale, design and methods of a 3-armed randomized controlled trial.

Authors:  Alison L Drake; Jennifer A Unger; Keshet Ronen; Daniel Matemo; Trevor Perrier; Brian DeRenzi; Barbra A Richardson; John Kinuthia; Grace John-Stewart
Journal:  Contemp Clin Trials       Date:  2017-03-14       Impact factor: 2.226

3.  Assessing Option B+ retention and infant follow-up in Lilongwe, Malawi.

Authors:  Blake M Hauser; William C Miller; Hannock Tweya; Colin Speight; Tiwonge Mtande; Sam Phiri; L M Ball; Mina C Hosseinipour; Irving F Hoffman; Nora E Rosenberg
Journal:  Int J STD AIDS       Date:  2017-07-27       Impact factor: 1.359

4.  Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: Systematic Review and Meta-Analysis of Studies in Africa.

Authors:  Brandon A Knettel; Cody Cichowitz; James Samwel Ngocho; Elizabeth T Knippler; Lilian N Chumba; Blandina T Mmbaga; Melissa H Watt
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-15       Impact factor: 3.731

5.  VITAL Start: Video-Based Intervention to Inspire Treatment Adherence for Life-Pilot of a Novel Video-Based Approach to HIV Counseling for Pregnant Women Living with HIV.

Authors:  Maria H Kim; Saeed Ahmed; Tapiwa Tembo; Rachael Sabelli; Robert Flick; Xiaoying Yu; Alick Mazenga; Holly Le Blond; Katie Simon; Miriam Hartig; Elizabeth Wetzel; Rose Nyirenda; Peter N Kazembe; Mtisunge Mphande; Angella Mkandawire; Mike J Chitani; Elaine J Abrams
Journal:  AIDS Behav       Date:  2019-11

6.  Vulnerable at Each Step in the PMTCT Care Cascade: High Loss to Follow Up During Pregnancy and the Postpartum Period in Tanzania.

Authors:  Cody Cichowitz; Festo Mazuguni; Linda Minja; Prosper Njau; Gretchen Antelman; James Ngocho; Brandon A Knettel; Melissa H Watt; Blandina T Mmbaga
Journal:  AIDS Behav       Date:  2019-07

7.  Cohort profile: the Hlabisa pregnancy cohort, KwaZulu-Natal, South Africa.

Authors:  Terusha Chetty; Claire Thorne; Frank Tanser; Till Bärnighausen; Anna Coutsoudis
Journal:  BMJ Open       Date:  2016-10-17       Impact factor: 2.692

8.  Unpacking Loss to Follow-Up Among HIV-Infected Women Initiated on Option B+ In Northern Tanzania: A Retrospective Chart Review.

Authors:  Festo Mazuguni; Boaz Mwaikugile; Cody Cichowitz; Melissa H Watt; Amasha Mwanamsangu; Blandina T Mmbaga; Prosper Njau; Michael J Mahande; Jim Todd; Jenny Renju
Journal:  East Afr Health Res J       Date:  2019-07-30

9.  Progress Toward the 90-90-90 HIV Targets in Zimbabwe and Identifying Those Left Behind.

Authors:  Avi J Hakim; Beth A Tippett Barr; Steven Kinchen; Godfrey Musuka; Julius Manjengwa; Shungu Munyati; Lovemore Gwanzura; Owen Mugurungi; Getrude Ncube; Suzue Saito; Bharat S Parekh; Hetal Patel; Yen T Duong; Elizabeth Gonese; Katrina Sleeman; Leala Ruangtragool; Jessica Justman; Amy Herman-Roloff; Elizabeth Radin
Journal:  J Acquir Immune Defic Syndr       Date:  2021-11-01       Impact factor: 3.771

10.  Retention in Care among HIV-Infected Pregnant Women in Haiti with PMTCT Option B.

Authors:  Jodie Dionne-Odom; Courtney Massaro; Kristen M Jogerst; Zhongze Li; Marie-Marcelle Deschamps; Cleonas Junior Destine; Redouin Senecharles; Moleine Moles Aristhene; Joseph Yves Domercant; Vanessa Rouzier; Peter F Wright
Journal:  AIDS Res Treat       Date:  2016-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.